TA-100

N/A

Report date: 2023/05/22 10:15:54

Base Information

Drug NameTA-100
Drug Alias NameTA-100
ClassificationBiologics
Mechanisms of ActionFibroblast growth factor receptor 3 antagonists
TargetsFibroblast growth factor receptor 3
Therapy Area/IndicationsAchondroplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversité De Nice Sophia Antipolis
China Registration ClassN/A

Develop Information

Active CompaniesUniversité De Nice Sophia Antipolis
Inactive CompaniesN/A
Active IndicationsAchondroplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A